The impact of increased CACNA1D expression during PCa response to hormone-therapy is not understood and may contribute to transcriptional regulation of genes governing cell survival mechanisms during the androgen-sensitive phase of treatment. Here, CACNA1D is linked to posterior cortical atrophy.